LabConnect Announces Technology Tracking for Sample Logistics

Johnson City, TN, June 5, 2025 – LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce its latest investments in global technology for clinical sample tracking. With the introduction of its enhanced sample tracking services “powered by RFID” the company looks to ensure higher priority and business continuity as samples move through delivery networks to its laboratories.

“Where every sample is a valued participant, we recognize that nothing should be left to chance in logistics. “ says Julia Tarasenko, Chief Commercial and Strategy Officer. Starting July 1^st, LabConnect intends to make the “powered by RFID” service available to customers and further accelerate its adoption by waving fees through the remainder of 2025. Julia adds that, “It’s our expectation that this enhanced visibility into sample tracking will create new levels of transparency and thereby improve staffing and resource planning. We see this as a necessary investment and benefit for participants and clients.”

In addition to the point-in-time tracking of samples to the laboratory, the new service will also offer LabConnect and clients with several expedited recovery capabilities. These include capabilities that allow for faster location of samples in distressed shipments and improved contingency planning by allowing packages to be pulled from existing logistics pathways should delays occur due to weather or other unforeseen events. This and other brokerage capabilities puts LabConnect samples on a priority fast-lane to laboratories around the world. Companies should contact their LabConnect representative to learn more about “powered by RFID” capabilities and restrictions.

About LabConnect

LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at www.labconnect.com and follow on LinkedIn.

LabConnect Media Contact:

Ashley Nichols
anichols@labconnect.com